LONDON, Dec. 13, 2021 /PRNewswire/ The Scottish Medicines Consortium has accepted for use by NHS Scotland, Accord's Sixmo? (buprenorphine implant) as a substitution treatment for opioid dependence
This report aims to support European businesses in navigating the challenges of the COVID-19 pandemic. The focus is on workplace practices and features that
Following a long recovery from the economic crisis (2007–2013), young people in the EU proved to be more vulnerable to the effects of the restrictions put in